Related Experiment Video
Updated: Jul 11, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Silencing E6/E7 Oncoproteins in SiHa Cells Treated with siRNAs and Oroxylum indicum Extracts Induced Apoptosis by
Noor Nabilah Talik Sisin1, Aaron Raphael Kong1, Hisham Atan Edinur1
1School of Health Sciences, Universiti Sains Malaysia, 16150, Kota Bharu, Kelantan, Malaysia.
Abstract:
E6 and E7 human papillomavirus (HPV) oncoproteins play a significant role in the malignant transformation of infected cervical cancer cells via suppression of tumour suppressor pathways by targeting p53 and pRb, respectively. This study aimed to investigate the anticancer effects of Oroxylum indicum (OI) leaves' methanol extract on SiHa cervical cancer cells. Expression of apoptosis-related proteins (Bcl-2, caspase (cas)-3, and cas-9), viral oncoproteins (E6 and E7), and tumour suppressor proteins (p53 and pRb) were evaluated using western blot analysis before and after E6/E7 small interfering RNAs (siRNAs) transfection. In addition, the E6/E7 mRNA expression levels were assessed with real-time (RT)-PCR. The present study showed that the OI extract effectively hindered the proliferation of SiHa cells and instigated increments of cas-3 and cas-9 expressions but decreased the Bcl-2 expressions. The OI extract inhibited E6/E7 viral oncoproteins, leading to upregulation of p53 and pRb tumour suppressor genes in SiHa cells. Additionally, combinatorial treatment of OI extract and gossypin flavonoid induced restorations of p53 and pRb. Treatment with OI extract in siRNA-transfected cells also further suppressed E6/E7 expression levels and further upregulations of p53 and pRb proteins. In conclusion, OI extract treatment on siRNAs-transfected SiHa cells can additively and effectively block E6- and E7-dependent p53 and pRb degradations. All these data suggest that OI could be explored for its chemotherapeutic potential in cervical cancer cells with HPV-integrated genomes.
Insights
Oroxylum indicum extract inhibits human papillomavirus (HPV) oncoproteins E6 and E7 in cervical cancer cells. This leads to the restoration of tumor suppressor proteins p53 and pRb, suggesting potential chemotherapeutic benefits.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Human papillomavirus (HPV) oncoproteins E6 and E7 drive cervical cancer by suppressing tumor suppressor pathways.
- Targeting p53 and pRb is crucial for blocking HPV-driven malignant transformation.
Purpose of the Study:
- To investigate the anticancer effects of Oroxylum indicum (OI) methanol extract on SiHa cervical cancer cells.
- To evaluate the impact of OI extract on apoptosis-related proteins, HPV oncoproteins, and tumor suppressor proteins.
Main Methods:
- Western blot analysis to assess protein expression (Bcl-2, caspase-3, caspase-9, p53, pRb, E6, E7).
- Real-time PCR (RT-PCR) to quantify E6/E7 mRNA levels.
- Treatment with OI extract, gossypin flavonoid, and E6/E7 small interfering RNAs (siRNAs).
Main Results:
- OI extract inhibited SiHa cell proliferation, increased caspase-3 and caspase-9, and decreased Bcl-2 expression.
- OI extract suppressed E6/E7 oncoproteins, upregulating p53 and pRb.
- Combined OI extract and gossypin restored p53 and pRb; OI extract in siRNA-transfected cells further reduced E6/E7 and increased p53/pRb.
Conclusions:
- OI extract effectively blocks E6/E7-dependent degradation of p53 and pRb in HPV-infected cervical cancer cells.
- OI extract demonstrates potential as a chemotherapeutic agent for cervical cancer with integrated HPV genomes.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
Abnormal Proliferation
MicroRNAs
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules

